JG
EPZM

Jefferies Group’s Epizyme, Inc EPZM Stock Holding History

Jefferies Group’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-25,700
Closed -$224K – 2141
2021
Q1 		$224K Hold
25,700
– – ﹤0.01% 1323
2020
Q4 		$279K Buy
+25,700
New +$317K ﹤0.01% 1295
2020
Q3 		– Sell
-19,300
Closed -$310 – 1629
2020
Q2 		$310 Sell
19,300
-78,800
-80% -$1.38M ﹤0.01% 1006
2020
Q1 		$1.52M Buy
98,100
+4,600
+5% +$98.8K 0.02% 805
2019
Q4 		$2.3M Buy
+93,500
New +$1.39M 0.02% 970

Other funds holding EPZM

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
KXA
KPCB XIII Associates Menlo Park, California $186M AUM 11.23% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

Jefferies Group's EPZM Position: Q2 2021 in Review

Jefferies Group sold out of Epizyme, Inc (EPZM) in Q2 2021, closing a stake of 22,828 shares — an estimated $199K sold.

Jefferies Group first reported a position in EPZM in Q4 2018 and held it in 7 quarters. The position peaked at $505K in Q2 2019. 126 funds tracked by Wall St. Rank hold EPZM as of Q2 2021.

  • Jefferies Group reported no remaining Epizyme, Inc position as of Q2 2021 after selling out during the quarter.
  • Jefferies Group sold 22,828 Epizyme, Inc shares in Q2 2021, an estimated $199K.
  • Jefferies Group first reported a position in Epizyme, Inc in Q4 2018 and held it in 7 quarters.
  • Jefferies Group's Epizyme, Inc position peaked at $505K in Q2 2019.
  • 126 funds tracked by Wall St. Rank held Epizyme, Inc as of Q2 2021.

Based on Jefferies Group's 13F filing for Q2 2021, filed 16 Aug 2021.